2025年3月最新中科院分区数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。近期推荐: | 热 SCI论文AI润色+人工QC服务 | 热 IF2.9,JCR Q2肿瘤学期刊征稿中 | 热 赛默飞基础学科研究有奖问卷 | 热 同行专家帮助选刊 |
![]() |
基本信息 | 登录收藏 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | PHARMACOLOGICAL RESEARCH PHARMACOL RES (此期刊被最新的JCR期刊SCIE收录) LetPub评分 8.1
71人评分
我要评分
声誉 8.7 影响力 7.3 速度 9.1 | |||||||||||||||||||||
期刊ISSN | 1043-6618 | 微信扫码收藏此期刊 | ||||||||||||||||||||
E-ISSN | 1096-1186 | |||||||||||||||||||||
2023-2024最新影响因子 (数据来源于搜索引擎) | 9.1 点击查看影响因子趋势图 | |||||||||||||||||||||
实时影响因子 | 截止2025年5月19日:10.23 | |||||||||||||||||||||
2023-2024自引率 | 2.20%点击查看自引率趋势图 | |||||||||||||||||||||
五年影响因子 | 9 | |||||||||||||||||||||
JCI期刊引文指标 | 2.12 | |||||||||||||||||||||
h-index | 118 | |||||||||||||||||||||
CiteScore ( 2024年最新版) |
| |||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||
期刊官方网站 | https://www.journals.elsevier.com/pharmacological-research | |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
期刊投稿网址 | https://www.editorialmanager.com/YPHRS | |||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足PHARMACOLOGICAL RESEARCH的语言要求,还能让PHARMACOLOGICAL RESEARCH编辑和审稿人得到更好的审稿体验,让稿件最大限度地被PHARMACOLOGICAL RESEARCH编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评(1篇) 论文致谢(7篇) 。
提交文稿 | |||||||||||||||||||||
是否OA开放访问 | No | |||||||||||||||||||||
通讯方式 | ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, 24-28 OVAL RD, LONDON, ENGLAND, NW1 7DX | |||||||||||||||||||||
出版商 | Academic Press Inc. | |||||||||||||||||||||
涉及的研究方向 | 医学-药学 | |||||||||||||||||||||
出版国家或地区 | ENGLAND | |||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||
出版周期 | Monthly | |||||||||||||||||||||
出版年份 | 1989 | |||||||||||||||||||||
年文章数 | 329点击查看年文章数趋势图 | |||||||||||||||||||||
Gold OA文章占比 | 37.17% | |||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 89.06% | |||||||||||||||||||||
WOS期刊SCI分区 ( 2023-2024年最新版) | WOS分区等级:1区
| |||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||
中国科学院SCI期刊分区 ( 2025年3月最新升级版) | 点击查看中国科学院SCI期刊分区趋势图
| |||||||||||||||||||||
中国科学院SCI期刊分区 ( 2023年12月升级版) |
| |||||||||||||||||||||
中国科学院SCI期刊分区 ( 2022年12月旧的升级版) |
| |||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1043-6618%5BISSN%5D | |||||||||||||||||||||
平均审稿速度 | 网友分享经验: 偏慢,4-8周 来源Elsevier官网: 平均5.5周 | |||||||||||||||||||||
平均录用比例 | 网友分享经验: 较易 | |||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在PHARMACOLOGICAL RESEARCH顺利发表。
快看看作者怎么说吧:服务好评(1篇) 论文致谢(7篇) 。 提交文稿 | |||||||||||||||||||||
在线出版周期 | 来源Elsevier官网: 平均6.7周 | |||||||||||||||||||||
期刊常用信息链接 |
|
|
|
|
中国学者近期发表的论文 | |
1. | Effects of natural products on macrophage immunometabolism: A new frontier in the treatment of metabolic diseases Author: Li, Jiani; Guo, Chen; Yang, Xiaofei; Xie, Weinan; Mi, Wenjing; Hua, Chenglong; Tang, Cheng; Wang, Han Journal: PHARMACOLOGICAL RESEARCH. 2025; Vol. 213, Issue , pp. -. DOI: 10.1016/j.phrs.2025.107634 PubMed DOI |
2. | Development of chimeric Nanobody-Granzyme B functionalized ferritin nanoparticles for precise tumor therapy Author: Xia, Baijin; Feng, Huolun; Jiang, Xinmiao; Guo, Jialing; Lin, Keming; Zhang, Wenxing; Xing, Fan; Cao, Lixue; Li, Yong; Zhang, Hui; Zhang, Xu; Li, Wenyu; Yu, Fei Journal: PHARMACOLOGICAL RESEARCH. 2025; Vol. 213, Issue , pp. -. DOI: 10.1016/j.phrs.2025.107628 PubMed DOI |
3. | Glutamine deprivation confers immunotherapy resistance by inhibiting IFN-γ signaling in cancer cells Author: Yuan, Zhiwei; Yu, Taiyan; Wang, Xu; Meng, Kelin; Wang, Tianlai; Wang, Boyu; Xi, Yu; Wang, Congjian; Zeng, Chenxi; Hu, Shaojie; Tian, Yitao; Xiong, Hui; Wang, Qi; Zou, Wenbin; Wang, Xue; Gao, Yi; Fu, Xiangning; Li, Lequn Journal: PHARMACOLOGICAL RESEARCH. 2025; Vol. 213, Issue , pp. -. DOI: 10.1016/j.phrs.2025.107643 PubMed DOI |
4. | Butyrate-engineered yeast activates Nppa and Sgcg genes and reduces radiation-induced heart damage via the gut-heart axis Author: Wu, Jiahao; Ji, Kaihua; Kang, Guangbo; Zhang, Manman; Wang, Jigang; Wang, Lina; Gao, Mengxue; Jia, Xiaoxiao; Lu, Xinran; Wang, Yan; Gao, Xinran; Guo, Yufei; Zhu, Zhixin; Wang, Qinghua; Zhao, Zhenyu; Liu, Qiang; Huang, He Journal: PHARMACOLOGICAL RESEARCH. 2025; Vol. 213, Issue , pp. -. DOI: 10.1016/j.phrs.2025.107642 PubMed DOI |
5. | Cardioprotective effect of crocin in patients with breast cancer receiving anthracycline-based chemotherapy: A randomized, double-blind, placebo-controlled study Author: Li, Xinye; Su, Xin; Liang, Wanping; Wang, Li; Yuan, Chao; Xu, Juping; Zhang, Yijun; Liu, Yan; Ma, Ning; Yang, Fan; Yang, Yiyuan; Tao, Liyuan; Sun, Shipeng; Shang, Hongcai; Xing, Yanwei Journal: PHARMACOLOGICAL RESEARCH. 2025; Vol. 213, Issue , pp. -. DOI: 10.1016/j.phrs.2025.107630 PubMed DOI |
6. | Histone lysine crotonylation accelerates ACSL4-mediated ferroptosis of keratinocytes via modulating autophagy in diabetic wound healing Author: Li, Fengjuan; Ye, Haowen; Li, Lanlan; Chen, Qingling; Lan, Xianwu; Wu, Liangxiu; Li, Bin; Li, Lishan; Guo, Chuxian; Ashrafizadeh, Milad; Sethi, Gautam; Guo, Jun; Wu, Liangyan Journal: PHARMACOLOGICAL RESEARCH. 2025; Vol. 213, Issue , pp. -. DOI: 10.1016/j.phrs.2025.107632 PubMed DOI |
7. | Gut microbiota derived DCA enhances FOLFOX efficacy via Ugt1a6b mediated enterohepatic circulation in colon cancer Author: Fang, Qian; Hou, Xiaoying; Fan, Limei; Deng, Yufei; Li, Xiaoxuan; Zhang, Hongyun; Wang, Haiping; Fu, Zhengqi; Sun, Binlian; Shu, Xiji; Du, Hongzhi; Liu, Yuchen Journal: PHARMACOLOGICAL RESEARCH. 2025; Vol. 213, Issue , pp. -. DOI: 10.1016/j.phrs.2025.107636 PubMed DOI |
8. | Inhibition of Kv1.3 channel restrains macrophage M2 polarization and ameliorates renal fibrosis via regulating STAT6 phosphorylation Author: Chen, Yanshan; Zhi, Yuanxing; Zhong, Hailin; Ma, Liang; Gu, Xinpei; Cai, Yijing; Huang, Jingjing; Yi, Xin; Wu, Xiaoyan; Yung, Ken Kin Lam; Zhou, Pingzheng Journal: PHARMACOLOGICAL RESEARCH. 2025; Vol. 213, Issue , pp. -. DOI: 10.1016/j.phrs.2025.107623 PubMed DOI |
9. | Hydrogels empowered mesenchymal stem cells and the derived exosomes for regenerative medicine in age-related musculoskeletal diseases Author: Liu, Lixin; Chen, Siwen; Song, Yantao; Cui, Longwei; Chen, Yiman; Xia, Jiangli; Fan, Yibo; Yang, Liqun; Yang, Lina Journal: PHARMACOLOGICAL RESEARCH. 2025; Vol. 213, Issue , pp. -. DOI: 10.1016/j.phrs.2025.107618 PubMed DOI |
10. | From bench to bedside: Developing CRISPR/Cas-based therapy for ocular diseases Author: Zhao, Qing; Wei, Linxin; Chen, Youxin Journal: PHARMACOLOGICAL RESEARCH. 2025; Vol. 213, Issue , pp. -. DOI: 10.1016/j.phrs.2025.107638 PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2025 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室